Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

Stock factor profile

Beta Drugs Ltd

BETA · Healthcare · Pharmaceuticals & Biotechnology

Beta Drugs Ltd. engages in the manufacturing and trading of pharmaceuticals. The company is headquartered in Panchkula, Haryana. The company went IPO on 2017-10-12. The firm offers a range of oncology products including tablets, capsules and injections. The firm offers a portfolio consisting of approximately 50 products catering to various oncology diseases, including breast, brain, bone, lung, mouth, head and neck, prostate, leukemia, lymphoma and supportive cancer and others. The Company’s oncology portfolio includes various brands, such as AB-PACLI, ADBIRON, ADCARB, ADCIST, Adlante, ADLEAP, ADMIDE, ADOXI, CAPAD, ADTHAL, Triodelta and others.

Last price₹2258.90
1 day+5.7%
1 month-4.0%
Model ratingLocked
Data as of03 Sep 2026

Performance

Price history

Equity review factors

Factor profile

Factor scores are part of the Wright portfolio review.

Run your free portfolio review

Fundamental snapshot

Fundamentals at a glance

Market cap2389
P/E ratio51.7
Factor betaLocked
VolatilityLocked
Model scoreLocked
Screen passLocked

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.